Staging of cancer of the pancreas. Cancer of the Pancreas Task Force
- PMID: 7272913
- DOI: 10.1002/1097-0142(19810315)47:6+<1631::aid-cncr2820471428>3.0.co;2-3
Staging of cancer of the pancreas. Cancer of the Pancreas Task Force
Abstract
A new protocol for staging carcinoma of the exocrine pancreas has been retrospectively evaluated in 924 cases abstracted from 14 clinics and hospitals; these patients were treated between January 1, 1950, and December 31, 1976. Significant differences (P less than .05) were observed in the survival rates of Stage I patients, Stage II--III patients, and Stage IV patients who could be evaluated for survival. The median survival of Stage I patients treated by pancreatic resection (6.0 months) was approached in Stage II--III unresected cases with or without bypass procedures; these patients received radiation and/or chemotherapy postoperatively. It is suggested that his protocol may be useful in prospective clinical therapeutic investigations for the evaluation of newer protocols of medical, surgical, and radiotherapeutic treatment.
MeSH terms
LinkOut - more resources
Medical